Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
There is a scarcity of drugs to either prevent or properly manage chemotherapy-induced neuropathic pain (CINP). Cannabis or cannabinoids have been reported to improve pain measures in patients with neuropathic pain. For this review, a search was done in PubMed for papers that examined the expression...
Saved in:
Main Author: | Willias Masocha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2018/5234943 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Anticonvulsant Enaminone E139 Attenuates Paclitaxel-Induced Neuropathic Pain in Rodents
by: Dhandapani Thangamani, et al.
Published: (2013-01-01) -
Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression
by: Nicole R. Silva, et al.
Published: (2025-01-01) -
Neuropathic Pain in Animal Models of Nervous System Autoimmune Diseases
by: David H. Tian, et al.
Published: (2013-01-01) -
Characterisation of the effects of the chemotherapeutic agent paclitaxel on neuropathic pain-related behaviour, anxiodepressive behaviour, cognition, and the endocannabinoid system in male and female rats
by: Chiara Di Marino, et al.
Published: (2025-01-01) -
Methadone in the Treatment of Neuropathic Pain
by: Bruno Gagnon, et al.
Published: (2003-01-01)